-
2022 IPO, Venture Capital and M&A Reports
2.28.2022WilmerHale’s annual IPO, Venture Capital and M&A reports provide insights into market conditions, as well as comprehensive statistics and analysis that are hard to find elsewhere.
-
2022 Venture Capital Report
2.28.2022The 2022 Venture Capital Report offers an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as insights on a number of key topics.
-
Recent Venture Financings as Company Counsel: 2022
1.28.2022In 2021, we served as counsel in more than 250 venture financings raising approximately $20 billion, including some of the largest and most prominent deals of the year.
-
WilmerHale Advises Atom Computing in $15M Series A Funding
8.13.2021On July 21, 2021, Atom Computing, a fast-growing quantum computing startup, announced it has raised $15 million in Series A funding.
-
WilmerHale Advises GentiBio in $157M Series A Funding
8.11.2021On August 11, 2021, GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, announced it has closed a Series A financing generating immediate proceeds of $157 million.
-
WilmerHale Advises Embark Veterinary in $75M Series B Funding
7.27.2021On July 26, 2021, Embark Veterinary, Inc., the top rated provider of dog DNA tests, announced that it secured $75 million in a Series B funding round led by SoftBank.
-
WilmerHale Represents Workrise in $300M Series E Funding Round
5.24.2021On May 20, 2021, Workrise (formerly RigUp), the leading workforce management platform for the skilled trades, announced it has raised a $300 million Series E round. As it enlarges its footprint, Workrise offers trade workers access to training that equips them for energy and infrastructure jobs on the rise.
-
WilmerHale Represents Immuta in $90M Series D Funding
5.24.2021Immuta, the leading provider of cloud data access control, announced that it has secured $90 million in Series D funding.
-
WilmerHale Represents Acquco in $160M Series A Financing to Buy and Scale Amazon Third-Party Sellers
5.12.2021On May 11, 2021, Acquco, a platform focused on acquiring third-party sellers on Amazon, announced that it has closed a $160 million Series A round.
-
WilmerHale Represents Catch&Release in $14M Series A Financing
5.5.2021On April 20, 2021, Catch&Release, a creative technology company for the next generation of commercial production, announced it has secured $14 million in Series A funding to help brands break free from the limitations of stock photography.
-
WilmerHale Advises Datanomix in $6M Series A Funding Round
5.4.2021On May 4, 2021, Datanomix, leading vendor of production intelligence software for industrial manufacturers, announced it has raised $6 million in Series A funding.
-
2021 IPO, Venture Capital and M&A Reports
4.26.2021WilmerHale’s annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.
-
2021 Venture Capital Report
4.26.2021The 2021 Venture Capital Report offers an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as insights on a number of key topics.
-
WilmerHale Represents ExecOnline in $45M Series D Funding Round
4.21.2021ExecOnline, the pioneer of online leadership development for enterprises, announced a Series D funding round of $45 million led by OMERS Growth Equity.
-
WilmerHale Advises Volastra Therapeutics in Extended $44M Seed Financing
4.6.2021On April 6, 2021, Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of metastatic cancer, announced the extension of its original $12 million seed round to a total of $44 million.
